A PERSONALIZED AND THOUGHTFUL APPROACH
Berkadia Medical & Life Sciences provides a client experience unique to its peers. We combine deep capital markets expertise, operational excellence and in-house marketing and design to ensure best-in-class service rooted in Berkadia's core values.
At Berkadia, we strive to be your trusted advisor, not your typical 'broker.' As a privately held firm, we are able to take the long view and always put our clients’ interests first.
Whether you're seeking a value-add investment in an up-and-coming market, the disposition of a core medical office portfolio, or the refinancing of a life sciences asset, our team of specialized experts in investment sales and mortgage banking is here for you.
Superior expertise, unparalleled execution and consistent speed to market, combined with Berkadia’s world-class platform gives clients the winning edge. We are pushing healthcare real estate advisory to the next level.
SABRINA SOLOMIANY Senior Managing Director, Head of Medical & Life Sciences BerkadiaIT'S IN OUR DNA.
Our mission is inspired by our two shareholders who created and remain the majority stakeholders in Berkadia— Berkshire Hathaway and Jefferies Financial Group. Both firms are renowned for their capital strength, sophisticated investment strategies and exacting attention to their clients’ diverse needs.
We’re honored to continue the Berkadia legacy in everything we do. When you work with us, you’re more than a client, and more than a partner. You’re a member of our family.
Mortgage Banking
Your projects, of any size and location, benefit from best- in - class financing partners and unparalleled access to capital.
Servicing
Get customized solutions and seamless service with our established resources and proven expertise.
Investment Sales
When you equip the right professionals with industry-leading insights and tools, the result is better investment outcomes.
Technology
Advanced decision-making with actionable insights backed by our powerful data.
POST MARKET SURVEILLANCE & PATIENT SUPPORT
LAUNCH & COMMERCIAL
MANUFACTURING & SUPPLY CHAIN
CLINICAL DEVELOPMENT
RESEARCH & DISCOVERY
SUCCESS IS NOT PURELY MEASURED BY NUMBERS.
But, they help tell our story: $5 billion Medical & Life Sciences investment sales volume since 2018
$2.4 billion Medical & Life Sciences portfolio and single-asset recapitalizations since 2018
*Career production statistics
$1 billion Medical & Life Sciences loan originations since 2018
41 states
We have a national presence, closing transactions in 41 states and counting
MEDICAL & LIFE SCIENCES
Sabrina Solomiany Senior Managing Director, Head of Medical & Life Sciences404.536.5054
sabrina.solomiany @ berkadia.com
Sabrina Solomiany joined Berkadia in June 2022 and is a Senior Managing Director and the Head of Medical & Life Sciences. She specializes in providing healthcare and life sciences real estate investors with acquisition, disposition, debt placement and recapitalization strategies. Ms. Solomiany's expertise spans various specialties of healthcare real estate including medical office buildings, life sciences, inpatient rehabilitation facilities, shortand long-term acute care hospitals, behavioral health, surgical hospitals, cancer centers, proton therapy, specialty hospitals, free-standing emergency departments, micro hospitals and urgent cares. Her clients include REITs, institutional investors, healthcare providers, developers and private capital investors.
Chris Lashmet Managing Director847.209.0425
chris.lashmet @ berkadia.com
Chris Lashmet joined Berkadia in 2022 and is a Managing Director of Medical & Life Sciences. Prior to Berkadia, Mr. Lashmet co-led the Medical Office group at Blueprint Healthcare Real Estate Advisors with his business partner Eric Lee. Together, they founded the new division at Blueprint, grew a team, and experienced significant early success in the market. They closed 20 medical office transactions valued at $170 million during their tenure at Blueprint across various deal profiles, spread throughout the country.
Eric Lee
Managing Director
763.226.8563
eric.lee @ berkadia.com
Eric Lee joined Berkadia in 2022 and is a Managing Director of Medical & Life Sciences. Prior to Berkadia, Mr. Lee co-led the Medical Office group at Blueprint Healthcare Real Estate Advisors with his business partner Chris Lashmet. Together, they founded the new division at Blueprint, grew a team, and experienced significant early success in the market. They closed 20 medical office transactions valued at $170 million during their tenure at Blueprint across various deal profiles, spread throughout the country.
Mike Cerny
Vice President – Originations
224.458.9829
mike.cerny @ berkadia.com
Mike Cerny joined Berkadia Medical & Life Sciences in November 2022 as Vice President –Originations and Lead Underwriter. Mike leads the underwriting team and also focuses on debt placement and JV equity structuring. He is an accomplished senior level professional with over 20 years of diverse experience in commercial real estate, healthcare finance.
312.845.8573
patrick.abeln @ berkadia.com
Patrick Abeln joined Berkadia in July 2023 as Director for Medical and Life Sciences. Patrick focuses on debt placement and JV equity structuring and is a senior level professional with 14 years of experience, including over nine years in healthcare real estate.
He has served in various roles, most recently as Assistant Vice President responsible for sourcing all financing on acquisition and development projects. He was directly responsible for sourcing over $3 billion in debt from lenders nationwide.
Megan Esqueda
Associate Operations Director
470.681.1394
megan.esqueda @ berkadia.com
Megan Esqueda joined Berkadia in July 2022 and serves as the Associate Operations Director for Medical & Life Sciences. In this role, Megan provides operational leadership, tactical planning, and marketing and transaction management. She also assists with the team’s workflow, maintaining the client database, and implementing new procedures to streamline the overall function of the group.
Madison Strasmann Associate949.887.3094
madison.strasmann @ berkadia.com
Madison Strasmann joined Berkadia in May 2023 as an Associate specializing in investment sales and mortgage banking. Prior to joining Berkadia, she was an Associate for CBRE’s U.S. Healthcare and Life Sciences Capital Markets team, focusing on debt placement and structured finance strategies for private investors, physicians, and regional physician groups. Madison worked on numerous financing assignments for a consideration of nearly $200 million. Her experience spans various specialties of healthcare real estate including medical office buildings, inpatient rehabilitation facilities, micro-hospitals, ambulatory surgical centers, urgent cares, and life sciences facilities.
George Desloge
Senior Financial Analyst
312.845.5162
george.desloge @ berkadia.com
George Desloge joined Berkadia in 2023 as a Senior Financial Analyst for Medical & Life Sciences. George started his real estate career with Newmark as a Research Analyst where he developed and maintained a proprietary database of market fundamentals and assisted brokerage groups with client acquisition and relocation. In 2019, George transitioned into Newmark’s Appraisal and Valuations Department. As an appraiser, he valued over 350 properties, totaling over $1.5 billion of all asset types including office, retail and industrial. George has experience working with a variety of clients including banks, life companies, pension funds, special servicers, and REITs.
Berkadia is proud to collaborate with global property consultancy Knight Frank to offer our clients unparalleled access to the world’s most active investors, spanning all key capital hubs to enable deeper relationships with diverse sources. As we continue to expand our capabilities as full-service, tech-enabled advisors dedicated to better serving the needs of our clients, this strategic alliance deeply broadens our reach, market exposure and relationships around the globe, allowing our clients to achieve their real estate goals and objectives. Together, we will be a dominant player in the marketplace.
Knight Frank’s 125-year legacy as the largest privatelyowned capital markets platform fully complements Berkadia’s industry-leading Investment Sales, Mortgage Banking and Servicing capabilities, allowing us to deliver clients greater value and more investment opportunities.
Together, Knight Frank and Berkadia offer a combined global network comprising more than 24,500 people across 560 offices in 53 territories, spanning all key capital hubs.
Our newly-formed alliance offers clients greater access to the world’s broader institutional, private, sovereign wealth and ultra-high-net-worth investor network.
Berkadia’s culture, principles and shared mission align with Knight Frank’s. From our people-first, clientcentric and community-focused mindset, to our integrity and shared commitment to excellence, our collective goal is to enhance people’s lives and environments.
United Kingdom
4 Territories
England | Scotland
Europe
17 Territories
Austria | Belgium | Bulgaria
Czech Republic | France
Germany | Greece | Hungary
Ireland | Italy | The Netherlands
Wales | Jersey Asia Pacific
3,030+ 79 OFFICES
PEOPLE
Poland | Portugal | Romania
Serbia | Spain | Switzerland
PEOPLE 1,040+ 67 OFFICES
16 Territories
Australia | Cambodia | China
Fiji | Hong Kong | India
Indonesia | Japan | Malaysia
New Zealand | Philippines
Singapore | South Korea
Taiwan | Thailand | Vietnam
10,570+ 153 OFFICES PEOPLE 120+ 6 OFFICES PEOPLE 600+ 23 OFFICES
The Middle East
4 Territories
Africa
9 Territories
Botswana | Kenya | Malawi
Nigeria | South Africa
Tanzania | Uganda
Zambia | Zimbabwe
Bahrain | Qatar
Saudi Arabia | UAE
PEOPLE
CLOSING IS JUST THE END OF THE BEGINNING.
We’re in this for the long haul. To us, every deal is the start of a new relationship or the continuation of one built on performance and trust. Our clients are family, and we’re relentlessly focused on your long-term success.
BERKADIA LOCATIONS
Investment Sales (IS)
Mortgage Banking (MB)
Both IS & MB
Closed Transactions